Status:
ACTIVE_NOT_RECRUITING
A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
Lead Sponsor:
University of Rochester
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The objective of this study is to conduct a pilot randomized trial to evaluate the preliminary efficacy of the UR-GOAL tool in improving SDM and communication between 100 older patients with AML and t...
Detailed Description
The investigators have developed a patient-centered communication tool (University of Rochester-Geriatric Oncology assessment for Acute myeloid Leukemia or UR-GOAL) that 1) conducts assessments of fit...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients
- Age ≥60 years
- Newly diagnosed AML or being worked up for possible AML
- Able to provide informed consent
- Agreement of their oncologist to participate in the study
- English-speaking
- If patients screen positive for cognitive impairment on the Mini-Cog test performed as part of the baseline assessment, they can still enroll if they are able to provide informed consent and have decision making capacity as determined by their treating oncologist
- Caregivers
- Selected by the patient when asked if there is a "family member, partner, friend or caregiver \[age 21 or older\] with whom the patient discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient
- Able to provide informed consent
- English-speaking
- Oncologists
- A practicing oncologist
- At least one of their patients are recruited to the study
- English-speaking
Exclusion
Key Trial Info
Start Date :
June 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05335369
Start Date
June 17 2022
End Date
October 31 2025
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14642